DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant  x                             Filed by a Party other than the Registrant  ¨

Check the appropriate box:

 

¨   Preliminary Proxy Statement
¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨   Definitive Proxy Statement
x   Definitive Additional Materials
¨   Soliciting Material Pursuant to §240.14a-12

AVEO PHARMACEUTICALS, INC.

(Name of Registrant as Specified in Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x   No fee required.
¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

¨   Fee paid previously with preliminary materials:
¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount previously paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

¨

 

 

Preliminary Proxy Statement

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on June 19, 2014

 

    

 

Meeting Information            

 

    

Meeting Type:

 

 

  Annual Meeting

 

   AVEO PHARMACEUTICALS INC   For holders as of:     April 22, 2014
    

 

Date: June 19, 2014

 

 

 

  Time: 10:00 AM EDT

 

     Location:   the offices of
    

   Wilmer Cutler Pickering Hale

    

   and Dorr LLP,

    

   60 State Street,

    

   Boston, Massachusetts 02109

 

     You are receiving this communication because you hold shares in the above named company.

AVEO PHARMACEUTICALS INC.

650 EAST KENDALL STREET

CAMBRIDGE, MA 02142

  This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
    

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

     See the reverse side of this notice to obtain proxy materials and voting instructions.

0000212952_1    R1.0.0.51160


        Before You Vote         
        

How to Access the Proxy Materials

 

Proxy Materials Available to VIEW or RECEIVE:

   

 

1. Notice & Proxy Statement    2. Form 10-K    3. Shareholder Letter

 

How to View Online:

 

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

 

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

                                 1) BY INTERNET:         www.proxyvote.com

                                 2) BY TELEPHONE:     1-800-579-1639

                                 3) BY E-MAIL*:              sendmaterial@proxyvote.com

 

* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 05, 2014 to facilitate timely delivery.

 

   

 

        How To Vote         
        

Please Choose One of the Following Voting Methods

 

      

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

    

0000212952_2     R1.0.0.51160


Voting items      

 

The Board of Directors recommends you vote FOR the following:

     
1.    Election of Directors                           
   Nominees                           
01    Kenneth M. Bate    02    Anthony B. Evnin    03    Tuan Ha-Ngoc    04    Raju Kucherlapati    05    Henri A. Termeer   
06    Robert C. Young                           

The Board of Directors recommends you vote FOR proposals 2, 3 and 4.

 

2. To approve Amendment No. 1 to the Amended and Restated 2010 Stock Incentive Plan

 

3. To approve an advisory vote on executive compensation

 

4. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2014

NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof.

0000212952_3    R1.0.0.51160


 

 

 

 

0000212952_4    R1.0.0.51160